The committee ultimately reached a different recommendation, but the staff analysis remains important because it shows where FDA found the record incomplete
REFERENCES Forman, H
Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach
So you use the steroid again
Include vegetables at every meal
For example, a 2020 study gave 202 people with mild mental impairment and low or low-normal B12 levels and elevated homocysteine levels B12 replacement therapy for 3 months ( After the treatment, 84% of the participants reported significant improvements in symptoms, like poor focus, memory decline, and forgetfulness ( Glossitis is a medical term that refers to an inflamed, red, and painful tongue